Header cover image

Pakistani (KSE) Pharma Industry Analysis

UpdatedFeb 06, 2025
DataAggregated Company Financials
Companies11
  • 7D-2.0%
  • 3M35.1%
  • 1Y169.7%
  • YTD-1.1%

Over the last 7 days, the Pharma industry has dropped 2.0%, driven by a pullback from Abbott Laboratories (Pakistan) of 2.0%. Meanwhile, Ferozsons Laboratories actually outperformed within the industry, gaining 5.2% in the last week. This takes the industry's 12 month performance to a gain of 170%.

Industry Valuation and Performance

Has the Pakistani Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 07 Feb 2025PK₨482.8bPK₨257.1bPK₨19.2b23.1x25.2x1.9x
Sun, 05 Jan 2025PK₨485.7bPK₨257.1bPK₨19.2b23.1x25.4x1.9x
Tue, 03 Dec 2024PK₨444.4bPK₨257.0bPK₨19.0b21.9x23.4x1.7x
Thu, 31 Oct 2024PK₨343.6bPK₨253.6bPK₨18.7b18.4x18.4x1.4x
Sat, 28 Sep 2024PK₨278.9bPK₨251.2bPK₨12.3b16.8x22.6x1.1x
Mon, 26 Aug 2024PK₨267.7bPK₨243.6bPK₨8.3b18.4x32.4x1.1x
Wed, 24 Jul 2024PK₨240.2bPK₨243.6bPK₨8.3b16.8x29x1x
Fri, 21 Jun 2024PK₨244.7bPK₨243.6bPK₨8.3b16.6x29.6x1x
Sun, 19 May 2024PK₨229.3bPK₨234.6bPK₨9.0b27.8x25.3x1x
Tue, 16 Apr 2024PK₨185.9bPK₨228.8bPK₨6.6b34.8x28.3x0.8x
Thu, 14 Mar 2024PK₨165.7bPK₨222.9bPK₨6.3b20.5x26.1x0.7x
Sat, 10 Feb 2024PK₨163.9bPK₨221.2bPK₨6.3b20.3x26.1x0.7x
Mon, 08 Jan 2024PK₨171.5bPK₨221.2bPK₨6.3b20.6x27.3x0.8x
Wed, 06 Dec 2023PK₨173.9bPK₨218.2bPK₨6.2b21.7x28.1x0.8x
Fri, 03 Nov 2023PK₨141.9bPK₨214.9bPK₨6.9b21.3x20.6x0.7x
Sun, 01 Oct 2023PK₨123.9bPK₨209.9bPK₨7.3b11.9x17x0.6x
Tue, 29 Aug 2023PK₨127.8bPK₨205.6bPK₨8.7b11.6x14.6x0.6x
Thu, 27 Jul 2023PK₨139.2bPK₨205.6bPK₨8.7b12.8x16x0.7x
Sat, 24 Jun 2023PK₨123.7bPK₨205.6bPK₨8.7b11.7x14.2x0.6x
Mon, 22 May 2023PK₨139.8bPK₨199.5bPK₨11.6b12.7x12x0.7x
Wed, 19 Apr 2023PK₨137.0bPK₨194.2bPK₨13.8b9.4x9.9x0.7x
Fri, 17 Mar 2023PK₨146.3bPK₨191.5bPK₨15.1b9.6x9.7x0.8x
Sun, 12 Feb 2023PK₨153.1bPK₨189.4bPK₨15.2b10.2x10.1x0.8x
Tue, 10 Jan 2023PK₨154.3bPK₨189.4bPK₨15.2b10x10.1x0.8x
Thu, 08 Dec 2022PK₨175.1bPK₨188.7bPK₨15.0b12x11.7x0.9x
Sat, 05 Nov 2022PK₨192.3bPK₨187.0bPK₨15.5b12.4x12.4x1x
Mon, 03 Oct 2022PK₨198.3bPK₨179.3bPK₨18.4b10.6x10.8x1.1x
Wed, 31 Aug 2022PK₨207.5bPK₨169.3bPK₨21.5b9.8x9.6x1.2x
Fri, 29 Jul 2022PK₨205.4bPK₨169.3bPK₨21.5b10.2x9.5x1.2x
Sun, 26 Jun 2022PK₨205.7bPK₨167.9bPK₨21.4b9.2x9.6x1.2x
Tue, 24 May 2022PK₨206.2bPK₨163.7bPK₨21.2b9.4x9.7x1.3x
Thu, 21 Apr 2022PK₨224.4bPK₨161.9bPK₨21.1b10.1x10.6x1.4x
Sat, 19 Mar 2022PK₨225.8bPK₨160.7bPK₨19.6b11x11.5x1.4x
Mon, 14 Feb 2022PK₨240.5bPK₨160.5bPK₨20.0b11.5x12x1.5x
Price to Earnings Ratio

12x


Total Market Cap: PK₨240.5bTotal Earnings: PK₨20.0bTotal Revenue: PK₨160.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Pakistani Pharma Industry Price to Earnings3Y Average 17.8x202320242025
Current Industry PE
  • Investors are optimistic on the Pakistani Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 25.2x which is higher than its 3-year average PE of 17.7x.
  • The 3-year average PS ratio of 1.0x is lower than the industry's current PS ratio of 1.9x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 17% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Pakistani Healthcare industry?

PK Market0.31%
Healthcare-1.83%
Pharma-2.00%
Pharma-2.00%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FEROZ Ferozsons LaboratoriesPK₨348.525.2%
+PK₨742.0m
44.9%PE23.7x
HINOON Highnoon LaboratoriesPK₨880.480.6%
+PK₨285.1m
73.3%PE15.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ABOT

PK₨1,250.00

Abbott Laboratories (Pakistan)

7D

-2.0%

1Y

186.7%

LIVEN

PK₨138.13

Liven Pharmaceuticals

7D

-4.7%

1Y

1,274.4%

HPL

PK₨2,861.00

Hoechst Pakistan

7D

-3.1%

1Y

104.4%

SEARL

PK₨103.97

Searle

7D

-3.6%

1Y

99.8%

BFBIO

PK₨203.10

BF Biosciences

7D

-9.6%

1Y

n/a

OTSU

PK₨173.62

Otsuka Pakistan

7D

-8.6%

1Y

27.2%

HINOON

PK₨880.48

Highnoon Laboratories

7D

0.6%

1Y

73.3%

GLAXO

PK₨407.71

GlaxoSmithKline Pakistan

7D

-1.6%

1Y

397.2%

AGP

PK₨168.25

AGP

7D

-3.3%

1Y

149.4%

FEROZ

PK₨348.52

Ferozsons Laboratories

7D

5.2%

1Y

44.9%